Beijing, China
January 6, 2009
Source:
SciDevNet
by Yuan Yue and Jia Hepeng
China has made moves to bring its patent law in line with
international standards and increase the filing of patents by
Chinese innovators in foreign countries.
The amendment to the patent law, passed by China's legislature —
the Standing Committee of the National People's Congress — last
month (27 December), is the third change to the law since it was
created in 1984.
Two previous revisions, in 1992 and 2000, aimed to enable China
to absorb foreign technologies and abide by World Trade
Organization rules. But this new effort is focused on improving
innovation, said Chen Guangjun, director of the Standing
Committee's science and technology office, at a press conference
for the law revision.
The new law requires a patent application to meet an "absolute
standard for novelty" — by being totally new worldwide — rather
than the previously stipulated "relative novelty" requirement
that a technology is new in China.
Absolute novelty is used in many major developed countries, such
as the United States and those in Europe.
The law also encourages Chinese innovators to obtain foreign
patents, by deleting the previous stipulation that Chinese
citizens must first apply for Chinese patents before filing for
foreign patents.
The United States currently grants eight times as many South
Korean patent applications as Chinese ones, according to the
leading Chinese financial magazine Caijing.
The newspaper China Daily said that one goal of the changes is
to encourage Chinese inventors to file for patent rights.
Currently the revenue from up to 40 per cent of patents for core
domestic technologies in China goes to foreign patent holders,
it said.
A patent reviewer at the State Intellectual Property Office, who
declined to be identified, said that the higher benchmark — the
worldwide standard of absolute novelty — for patent applications
might not improve standards as reviewers have difficulty finding
out whether a similar invention has been authorised in other
countries.
He is echoed by Lin Xiaodong, director of the patent management
office at the Peking University Health Science Center, who added
that high costs often prevent Chinese innovators from applying
for patents in foreign countries.
The revised patent law will take effect on 1 October this year.
Besides the above revisions, it also includes stipulations on
mandatory patent licensing — such as on HIV/AIDS drugs in time
of the public health crisis. |
|
中文 |
|
With the new "absolute"
principle, a Chinese patent can
only be given to an invention or
technology that is totally new
worldwide |
|